Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders' (Deficit) Equity

v2.4.0.8
Consolidated Statements of Changes in Stockholders' (Deficit) Equity (USD $)
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance at Sep. 30, 2012 $ (2,772,435) $ 5,645 $ 0 $ (2,778,080)
Beginning balance (in shares) at Sep. 30, 2012   5,645,212    
Net loss (1,853,791) 0 0 (1,853,791)
Equity acquired in reverse merger 0 41,500 (41,500) 0
Equity acquired in reverse merger (in shares)   41,500,000    
Issuance of common stock and 2,500,000 warrants to purchase 2,500,000 shares of common stock on June 26 for $1,250,000 ($0.50 per share) 1,250,000 2,500 1,247,500 0
Issuance of common stock and 2,500,000 warrants to purchase 2,500,000 shares of common stock on June 26 for $1,250,000 ($0.50 per share) (in shares)   2,500,000    
Exchange of debt for common stock 2,470,022 9,000 2,461,022 0
Exchange of debt for common stock (in shares)   9,000,025    
500,000 warrants to purchase 500,000 shares of common stock on July 3 for $250,000 ($0.50 per share) 250,000 500 249,500 0
500,000 warrants to purchase 500,000 shares of common stock on July 3 for $250,000 ($0.50 per share) (in shares)   500,000    
Issuance of common stock and 1,000,000 warrants to purchase 1,000,000 shares of common stock on August 30 for $500,000 ($0.50 per share) 500,000 1,000 499,000 0
Issuance of common stock and 1,000,000 warrants to purchase 1,000,000 shares of common stock on August 30 for $500,000 ($0.50 per share) (in shares)   1,000,000    
Grant of one warrant to purchase 145,985 shares of common stock issued with note payable on September 30 55,293 0 55,293 0
Stock based compensation expense 287,927 0 287,927 0
Ending balance at Sep. 30, 2013 187,016 60,145 4,758,742 (4,631,871)
Ending balance (in shares) at Sep. 30, 2013   60,145,237    
Net loss (8,142,823) 0 0 (8,142,823)
Issuance of restricted stock for services 94,875 275 94,600 0
Issuance of restricted stock for services (in shares)   275,000    
Exercise of stock options 92,500 231 92,269 0
Exercise of stock options (in shares) 231,250 231,250    
Issuance of stock in Private Placement Funding (225,297) 11,400 (236,697) 0
Issuance of stock in Private Placement Funding (in shares)   11,400,000    
Stock based compensation expense 1,101,286 0 1,101,286 0
Ending balance at Sep. 30, 2014 $ (6,892,443) $ 72,051 $ 5,810,200 $ (12,774,694)
Ending balance (in shares) at Sep. 30, 2014   72,051,487